430 related articles for article (PubMed ID: 22135472)
21. Evolution of the human immunodeficiency virus type 1 protease: effects on viral replication capacity and protease robustness.
Capel E; Martrus G; Parera M; Clotet B; Martínez MA
J Gen Virol; 2012 Dec; 93(Pt 12):2625-2634. PubMed ID: 22933665
[TBL] [Abstract][Full Text] [Related]
22. Rapid detection of drug resistant HIV -1 to reverse transcriptase and protease inhibitors in HIV-infected patients receiving highly active antiretroviral therapies.
Yu M; Kabat W; Wang J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Dec; 14(4):325-9. PubMed ID: 11471017
[TBL] [Abstract][Full Text] [Related]
23. Diversity of human immunodeficiency virus type 1 subtype A and CRF03_AB protease in Eastern Europe: selection of the V77I variant and its rapid spread in injecting drug user populations.
Roudinskii NI; Sukhanova AL; Kazennova EV; Weber JN; Pokrovsky VV; Mikhailovich VM; Bobkov AF
J Virol; 2004 Oct; 78(20):11276-87. PubMed ID: 15452247
[TBL] [Abstract][Full Text] [Related]
24. A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance.
Steegen K; Demecheleer E; De Cabooter N; Nges D; Temmerman M; Ndumbe P; Mandaliya K; Plum J; Verhofstede C
J Virol Methods; 2006 May; 133(2):137-45. PubMed ID: 16375980
[TBL] [Abstract][Full Text] [Related]
25. Polyamide nucleic acid targeted to the primer binding site of the HIV-1 RNA genome blocks in vitro HIV-1 reverse transcription.
Lee R; Kaushik N; Modak MJ; Vinayak R; Pandey VN
Biochemistry; 1998 Jan; 37(3):900-10. PubMed ID: 9454580
[TBL] [Abstract][Full Text] [Related]
26. Template-directed pausing of DNA synthesis by HIV-1 reverse transcriptase during polymerization of HIV-1 sequences in vitro.
Klarmann GJ; Schauber CA; Preston BD
J Biol Chem; 1993 May; 268(13):9793-802. PubMed ID: 7683663
[TBL] [Abstract][Full Text] [Related]
27. [HIV genotypic mutation selectively induced by the protease inhibitor nelfinavir at codon 30. Case series and consequences for antiretroviral management].
Manfredi R; Calza L
Infez Med; 2002 Sep; 10(3):151-6. PubMed ID: 12704265
[TBL] [Abstract][Full Text] [Related]
28. Collinearity of protease mutations in HIV-1 samples with high-level protease inhibitor class resistance.
Babrzadeh F; Varghese V; Pacold M; Liu TF; Nyrén P; Schiffer C; Fessel WJ; Shafer RW
J Antimicrob Chemother; 2013 Feb; 68(2):414-8. PubMed ID: 23085775
[TBL] [Abstract][Full Text] [Related]
29. Genetic Diversity and Drug Resistance of HIV-1 CRF55_01B in Guangdong, China.
Yu G; Li Y; Huang X; Zhou P; Yan J; Yan X; Fu X; Fang Y; Liu J; Li J; He X; Lin P
Curr HIV Res; 2020; 18(3):210-218. PubMed ID: 32294040
[TBL] [Abstract][Full Text] [Related]
30. Deep sequencing reveals minor protease resistance mutations in patients failing a protease inhibitor regimen.
Fisher R; van Zyl GU; Travers SA; Kosakovsky Pond SL; Engelbrech S; Murrell B; Scheffler K; Smith D
J Virol; 2012 Jun; 86(11):6231-7. PubMed ID: 22457522
[TBL] [Abstract][Full Text] [Related]
31. Misincorporation by HIV-1 reverse transcriptase promotes recombination via strand transfer synthesis.
Palaniappan C; Wisniewski M; Wu W; Fay PJ; Bambara RA
J Biol Chem; 1996 Sep; 271(37):22331-8. PubMed ID: 8798393
[TBL] [Abstract][Full Text] [Related]
32. HIV-1 DNA dynamics and variations in HIV-1 DNA protease and reverse transcriptase sequences in multidrug-resistant patients during successful raltegravir-based therapy.
Michelini Z; Galluzzo CM; Pirillo MF; Francisci D; Degli Antoni A; Vivarelli A; Ladisa N; Cirioni O; Weimer LE; Fragola V; Cara A; Floridia M; Baroncelli S
J Med Virol; 2016 Dec; 88(12):2115-2124. PubMed ID: 27197719
[TBL] [Abstract][Full Text] [Related]
33. Emergence of protease inhibitor resistance mutations in human immunodeficiency virus type 1 isolates from patients and rapid screening procedure for their detection.
Vasudevachari MB; Zhang YM; Imamichi H; Imamichi T; Falloon J; Salzman NP
Antimicrob Agents Chemother; 1996 Nov; 40(11):2535-41. PubMed ID: 8913459
[TBL] [Abstract][Full Text] [Related]
34. Performance of Celera RUO integrase resistance assay across multiple HIV-1 subtypes.
Wallis CL; Viana RV; Saravanan S; Silva de Jesus C; Zeh C; Halvas EK; Mellors JW
J Virol Methods; 2017 Mar; 241():41-45. PubMed ID: 27993614
[TBL] [Abstract][Full Text] [Related]
35. Genetic variability of HIV-1 protease from Nigeria and correlation with protease inhibitors drug resistance.
Vicente AC; Agwale SM; Otsuki K; Njouku OM; Jelpe D; Idoko JA; Caride E; Brindeiro RM; Tanuri A
Virus Genes; 2001 Mar; 22(2):181-6. PubMed ID: 11324755
[TBL] [Abstract][Full Text] [Related]
36. Monitoring resistance to human immunodeficiency virus type 1 protease inhibitors by pyrosequencing.
O'Meara D; Wilbe K; Leitner T; Hejdeman B; Albert J; Lundeberg J
J Clin Microbiol; 2001 Feb; 39(2):464-73. PubMed ID: 11158091
[TBL] [Abstract][Full Text] [Related]
37. "Wide-open" 1.3 A structure of a multidrug-resistant HIV-1 protease as a drug target.
Martin P; Vickrey JF; Proteasa G; Jimenez YL; Wawrzak Z; Winters MA; Merigan TC; Kovari LC
Structure; 2005 Dec; 13(12):1887-95. PubMed ID: 16338417
[TBL] [Abstract][Full Text] [Related]
38. RNA and DNA Sanger sequencing versus next-generation sequencing for HIV-1 drug resistance testing in treatment-naive patients.
Alidjinou EK; Deldalle J; Hallaert C; Robineau O; Ajana F; Choisy P; Hober D; Bocket L
J Antimicrob Chemother; 2017 Oct; 72(10):2823-2830. PubMed ID: 29091197
[TBL] [Abstract][Full Text] [Related]
39. Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing.
Salazar-Gonzalez JF; Bailes E; Pham KT; Salazar MG; Guffey MB; Keele BF; Derdeyn CA; Farmer P; Hunter E; Allen S; Manigart O; Mulenga J; Anderson JA; Swanstrom R; Haynes BF; Athreya GS; Korber BT; Sharp PM; Shaw GM; Hahn BH
J Virol; 2008 Apr; 82(8):3952-70. PubMed ID: 18256145
[TBL] [Abstract][Full Text] [Related]
40. Efficient extension of a misaligned tRNA-primer during replication of the HIV-1 retrovirus.
Das AT; Berkhout B
Nucleic Acids Res; 1995 Apr; 23(8):1319-26. PubMed ID: 7538660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
